JA
EN
中文
この記事のまとめ
MiSeq FGx Systemは、イルミナ（Illumina）社が開発した次世代シーケンサーで、特に法医学用途に特化しています。出生前親子鑑定においても高い精度を誇ります。
Details on Accuracy
精度の詳細
When using the MiSeq FGx System for non-invasive prenatal paternity testing (NIPPT), it analyzes cell-free fetal DNA (cffDNA) present in maternal plasma. Key features include:
High-precision DNA analysis
- By combining STR and SNP markers, the system achieves highly accurate paternity determination.
Studies have shown that, in 17 parent-child pairs, an accuracy rate of up to 94.12% was achieved.
Non-invasive method
- Since only a maternal blood sample is required, it carries far less risk compared to invasive procedures such as amniocentesis or chorionic villus sampling.
Rapid results
- With its fast analysis capabilities, the system delivers results in a short time frame.
About the ForenSeq MainstAY Kit
The ForenSeq MainstAY Kit targets 52 forensic DNA markers (27 autosomal STRs and 25 Y-STRs), achieving up to 99.82% accu...
Summary
As a next-generation sequencer widely used in the field of forensic science, the MiSeq FGx System also offers high accuracy and reliability in prenatal paternity testing. By leveraging the combination of STR and SNP markers, it enables non-invasive and rapid verification of paternity. For more information, refer to Illumina’s official website.
PAXgene Blood ccfDNA Tube
The PAXgene Blood ccfDNA Tube enables safe, non-invasive collection and long-term stabilization of circulating cell-free...
